1,098
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community

, , , , , , , , ORCID Icon, , & show all
Pages 1-13 | Received 05 Oct 2017, Accepted 03 Dec 2017, Published online: 07 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christiane Gerke, Phanramphoei N. Frantz, Katrin Ramsauer & Frédéric Tangy. (2019) Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya. Expert Review of Vaccines 18:4, pages 393-403.
Read now

Articles from other publishers (24)

Nicola Principi & Susanna Esposito. (2024) Development of Vaccines against Emerging Mosquito-Vectored Arbovirus Infections. Vaccines 12:1, pages 87.
Crossref
Ximena Flandes, Clairissa A. Hansen, Sunil Palani, Kaja Abbas, Cate Bennett, William Perea Caro, Raymond Hutubessy, Kanat Khazhidinov, Philipp Lambach, Clara Maure, Caroline Marshall, Diana P. Rojas, Alexander Rosewell, Sushant Sahastrabuddhe, Marta Tufet, Annelies Wilder-Smith, David W.C. Beasley, Nigel Bourne & Alan D.T. Barrett. (2023) Vaccine value profile for Chikungunya. Vaccine.
Crossref
Giuseppina Ortu, Gilda Grard, Fanny Parenton, Marc Ruello, Marie-Claire Paty, Guillaume André Durand, Youssouf Hassani, Henriette De Valk & Harold Noël. (2023) Long lasting anti-IgG chikungunya seropositivity in the Mayotte population will not be enough to prevent future outbreaks: A seroprevalence study, 2019. PLOS ONE 18:5, pages e0285879.
Crossref
Mohamad S. Hakim, Luthvia Annisa, Faris M. Gazali & Abu T. Aman. (2022) The origin and continuing adaptive evolution of chikungunya virus. Archives of Virology 167:12, pages 2443-2455.
Crossref
Sreeja R. Nair, Rachy Abraham & Easwaran Sreekumar. (2022) Generation of a Live-Attenuated Strain of Chikungunya Virus from an Indian Isolate for Vaccine Development. Vaccines 10:11, pages 1939.
Crossref
Maija T Suvanto, Ruut Uusitalo, Eveline Otte im Kampe, Tytti Vuorinen, Satu Kurkela, Olli Vapalahti, Timothée Dub, Eili Huhtamo & Essi M Korhonen. (2022) Sindbis virus outbreak and evidence for geographical expansion in Finland, 2021. Eurosurveillance 27:31.
Crossref
Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, Sotheary Sann, Nisa Ya, Polidy Pean, Philippe Dussart, Olivier Schwartz, Sovann Ly, Timothée Bruel, Sowath Ly, Veasna Duong, Erik A. Karlsson & Tineke Cantaert. (2022) Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort. Frontiers in Immunology 13.
Crossref
Roland Tschismarov, Raphaël M. Zellweger, Min Jie Koh, Yan Shan Leong, Jenny G. Low, Eng Eong Ooi, Christian W. Mandl, Katrin Ramsauer & Ruklanthi de Alwis. (2021) Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine. JCI Insight 6:21.
Crossref
Hapuarachchige Chanditha Hapuarachchi, Wing-Yan Wong, Carmen Koo, Wei-Ping Tien, Gladys Yeo, Jayanthi Rajarethinam, Eugene Tan, Suzanna Chiang, Chee-Seng Chong, Cheong-Huat Tan, Li-Kiang Tan & Lee-Ching Ng. (2021) Transient transmission of Chikungunya virus in Singapore exemplifies successful mitigation of severe epidemics in a vulnerable population. International Journal of Infectious Diseases 110, pages 417-425.
Crossref
Stylianos Bournazos, Hoa Thi My Vo, Veasna Duong, Heidi Auerswald, Sowath Ly, Anavaj Sakuntabhai, Philippe Dussart, Tineke Cantaert & Jeffrey V. Ravetch. (2021) Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372:6546, pages 1102-1105.
Crossref
Vinit Upasani, Carolina Scagnolari, Federica Frasca, Nikaïa Smith, Vincent Bondet, Axelle Vanderlinden, Sokchea Lay, Heidi Auerswald, Sothy Heng, Denis Laurent, Sowath Ly, Veasna Duong, Guido Antonelli, Philippe Dussart, Darragh Duffy & Tineke Cantaert. (2020) Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue. Frontiers in Immunology 11.
Crossref
Kate Zinszer, Andrea Caprara, Antonio Lima, Stéphanie Degroote, Monica Zahreddine, Kellyanne Abreu, Mabel Carabali, Katia Charland, Mayana Azevedo Dantas, José Wellington, Beatriz Parra, Florence Fournet, Emmanuel Bonnet, Denis Pérez, Emilie Robert, Christian Dagenais, Tarik Benmarhnia, Neil Andersson & Valéry Ridde. (2020) Sustainable, healthy cities: protocol of a mixed methods evaluation of a cluster randomized controlled trial for Aedes control in Brazil using a community mobilization approach. Trials 21:1.
Crossref
Sabrina Schrauf, Roland Tschismarov, Erich Tauber & Katrin Ramsauer. (2020) Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections. Frontiers in Immunology 11.
Crossref
Emily M. Webb, Sasha R. Azar, Sherry L. Haller, Rose M. Langsjoen, Candace E. Cuthbert, Anushka T. Ramjag, Huanle Luo, Kenneth Plante, Tian Wang, Graham Simmons, Christine V. F. Carrington, Scott C. Weaver, Shannan L. Rossi & Albert J. Auguste. (2019) Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential. Scientific Reports 9:1.
Crossref
Heidi Auerswald, Ana de Jesus, Gonçalo Seixas, Teresa Nazareth, Saraden In, Sokthearom Mao, Veasna Duong, Ana Clara Silva, Richard Paul, Philippe Dussart & Carla Alexandra Sousa. (2019) First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation. Parasites & Vectors 12:1.
Crossref
Andreas Suhrbier. (2019) Rheumatic manifestations of chikungunya: emerging concepts and interventions. Nature Reviews Rheumatology 15:10, pages 597-611.
Crossref
Fatih Anfasa, Stephanie M. Lim, Susan Fekken, Robert Wever, Albert D.M.E. Osterhaus & Byron E.E. Martina. (2019) Characterization of antibody response in patients with acute and chronic chikungunya virus disease. Journal of Clinical Virology 117, pages 68-72.
Crossref
Kyoko Hayashida, Yasuko Orba, Patricia C. Sequeira, Chihiro Sugimoto, William W. Hall, Yuki Eshita, Yutaka Suzuki, Lucky Runtuwene, Patricia Brasil, Guilherme Calvet, Cintia D. S. Rodrigues, Carolina C. dos Santos, Maria A. M. Mares-Guia, Junya Yamagishi, Ana M. B. de Filippis & Hirofumi Sawa. (2019) Field diagnosis and genotyping of chikungunya virus using a dried reverse transcription loop-mediated isothermal amplification (LAMP) assay and MinION sequencing. PLOS Neglected Tropical Diseases 13:6, pages e0007480.
Crossref
Muktha S. Natrajan, Alejandra Rojas & Jesse J. Waggoner. (2019) Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus. Journal of Clinical Microbiology 57:6.
Crossref
Laura I. Levi & Marco Vignuzzi. (2019) Arthritogenic Alphaviruses: A Worldwide Emerging Threat?. Microorganisms 7:5, pages 133.
Crossref
Christopher Maucourant, Caroline Petitdemange, Hans Yssel & Vincent Vieillard. (2019) Control of Acute Arboviral Infection by Natural Killer Cells. Viruses 11:2, pages 131.
Crossref
Victor R. DeFilippis. 2019.
Ann M Powers. (2018) Licensed chikungunya virus vaccine: a possibility?. The Lancet 392:10165, pages 2660-2661.
Crossref
Emil C Reisinger, Roland Tschismarov, Eckhard Beubler, Ursula Wiedermann, Christa Firbas, Micha Loebermann, Andrea Pfeiffer, Matthias Muellner, Erich Tauber & Katrin Ramsauer. (2018) Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. The Lancet 392:10165, pages 2718-2727.
Crossref